Stocks Comparison
Smith & Nephew vs STERIS: revenue, profit, margins and growth compared
Smith & Nephew brought in $6.2B of revenue in fiscal 2025, STERIS $5.9B in fiscal 2026. Revenue changed by +6.1% at Smith & Nephew and +8.7% at STERIS on the year before, so STERIS grew faster. Smith & Nephew kept 10.1% of its revenue as net profit, STERIS 13.2%.
Side by side, latest fiscal year
| SNN | STE | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2026 (March 31, 2026) |
| Revenue | $6.2B | $5.9B |
| Revenue growth | +6.1% | +8.7% |
| Net income | $625M | $782.3M |
| Net margin | 10.1% | 13.2% |
| Free cash flow | n/a | $972.4M |
| Free cash flow margin | n/a | 16.4% |
| Earnings per share (diluted) | $0.72 | $7.93 |
| Cash | $557M | $439.6M |
| Debt | $3.1B | $1.8B |
| Price to earnings | n/a | 26.6 |
| Market value | $11.5B | $20.6B |
| Dividend yield | n/a | 1.17% |
| Rank by revenue in sector | #56 of 742 · Health care | #58 of 742 · Health care |
Over the years
Questions about Smith & Nephew and STERIS
Which is bigger by revenue, Smith & Nephew or STERIS?
Smith & Nephew is bigger by revenue: $6.2B in fiscal 2025, against $5.9B for STERIS in fiscal 2026.
Which keeps more of its revenue as profit, Smith & Nephew or STERIS?
Smith & Nephew had a net margin of 10.1% in fiscal 2025; STERIS had 13.2% in fiscal 2026.
Which grew revenue faster, Smith & Nephew or STERIS?
In their latest fiscal years revenue changed by +6.1% at Smith & Nephew and +8.7% at STERIS.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.